valuestock image

acf/google-ad-placement

Biogen BIIB has outperformed the market over the past 15 years by 1.68% on an annualized basis producing an average annual return of 12.42%. Currently, Biogen has a market capitalization of $34.40 billion. 
Buying $100 In BIIB: If an investor had bought $100 of BIIB stock 15 years ago, it would be worth $575.86 today based on a price of $237.54 for BIIB at the time of writing.
<h3>Biogen's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2023/1698863412_0.png" alt="comp_fig" />

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Application error: a client-side exception has occurred (see the browser console for more information).